Testosterone replacement therapy and blood pressure medications can generally be used together, and many men take both safely under medical supervision. The combination is not contraindicated, but it does require closer monitoring than either medication alone, because testosterone can nudge blood pressure upward through several pathways. In 2025, the FDA updated testosterone product labeling to reflect that testosterone use does appear to raise blood pressure, while also noting no increase in the risk of serious cardiovascular events.1JAMA. FDA Updates Testosterone Labeling for Blood Pressure and Cardiovascular Risks The reality is more nuanced than a simple yes-or-no, and the details matter depending on which blood pressure drug you take, how your testosterone is delivered, and what else is going on with your health.
How Testosterone Affects Blood Pressure
The relationship between testosterone and blood pressure is not straightforward, and the evidence sometimes points in opposite directions depending on the study and population. A study of men using transdermal testosterone found an average increase of about 3.5 mmHg in 24-hour systolic blood pressure over 16 weeks. Among those already being treated for hypertension, the bump was slightly larger, around 4.5 mmHg, while men without hypertension saw a smaller and statistically uncertain increase.2Endocrine Practice. Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy That modest rise is what prompted the FDA’s labeling update.
But a separate long-term registry study of men receiving testosterone undecanoate injections told a different story. Those men actually experienced reductions in systolic blood pressure, with a median drop of about 12.5 mmHg over time. Interestingly, men taking blood pressure medications alongside their testosterone saw even larger reductions than those not on antihypertensives.3PubMed Central. Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men One plausible explanation is that restoring testosterone to normal levels in men who are genuinely deficient improves metabolic health in ways that benefit blood pressure over time, including reductions in body fat and insulin resistance. The conflicting findings may also reflect differences in formulations, treatment duration, and how sick the men were at baseline.
So the honest picture is that testosterone can push blood pressure up in the short term, especially through mechanisms like fluid retention, but in some men the longer-term metabolic benefits may offset or even reverse that initial rise. Your doctor cannot know in advance which direction you will trend, which is why blood pressure monitoring early in treatment matters.
The Mechanisms Behind Blood Pressure Changes
Testosterone influences blood pressure through at least three overlapping pathways. Understanding them helps explain why the effect varies so much from person to person and why your prescriber will track certain lab values carefully.
The first pathway involves sodium and fluid. Testosterone promotes sodium reabsorption in the kidneys, meaning the body holds on to more salt and, by extension, more water.4PubMed Central. Testosterone Increases: Sodium Reabsorption, Blood Pressure, and Renal Pathology in Female Spontaneously Hypertensive Rats on a High Sodium Diet The extra fluid in your bloodstream increases the volume your heart has to pump, which raises pressure. Clinical guidelines for testosterone therapy specifically recommend counseling patients about dietary sodium restriction and monitoring fluid intake to counter this effect.5International Braz J Urol. Management of Adverse Effects in Testosterone Replacement Therapy If you are already on a diuretic for blood pressure, this is a situation where one medication is trying to push fluid out while the hormone is pulling it back in. The balance usually works out fine, but it may require a dose adjustment.
The second pathway is through red blood cell production. Testosterone stimulates the bone marrow to produce more red blood cells, a process called erythropoiesis. More red blood cells thicken the blood, which can raise blood pressure and, in extreme cases, increase the risk of clots.6Sexual Medicine Reviews. Management of hematocrit levels for testosterone replacement patients, a narrative review This is the reason your doctor checks hematocrit levels repeatedly during the first year of testosterone therapy and periodically afterward. If your hematocrit climbs above about 52%, a therapeutic blood draw (phlebotomy) is the standard response.5International Braz J Urol. Management of Adverse Effects in Testosterone Replacement Therapy
The third pathway runs in the opposite direction and helps explain why not everyone sees blood pressure go up. Testosterone at normal physiological levels dilates blood vessels, including the coronary arteries. Research on men with coronary artery disease found that testosterone administered directly into the coronary arteries caused them to widen and increased blood flow.7PubMed. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease This vasodilating effect can lower blood pressure. In men who start with genuinely low testosterone and poor vascular function, this benefit may outweigh the fluid and red-blood-cell effects, resulting in an overall drop in blood pressure rather than a rise.
Does the Type of Testosterone Matter?
Testosterone comes in several forms: injections (usually every one to two weeks or in longer-acting formulations), transdermal patches and gels applied daily, and less commonly, implanted pellets or oral capsules. The pharmacokinetics differ substantially. Injections cause a spike in testosterone levels that gradually falls before the next dose, while patches and gels produce more stable day-to-day levels.8JAMA Internal Medicine. Comparative Safety of Testosterone Dosage Forms
These fluctuations matter for blood pressure because the spike-and-trough pattern of injections may temporarily drive more aggressive fluid retention and red blood cell production at peak levels than a steady-state gel delivers. The study that found a 3.5 mmHg systolic increase used a transdermal system, while the registry that found blood pressure decreases used testosterone undecanoate injections given every 12 weeks, which produce a smoother profile than shorter-acting injections. There is no head-to-head cardiovascular comparison between formulations, so no one can say definitively which is “safest” for someone on blood pressure medicine. In practice, clinicians often favor gels or patches for men with existing cardiovascular risk factors because the steadier levels are easier to manage, though this is a clinical judgment call rather than a hard evidence-based rule.
How Blood Pressure Drugs Can Affect Testosterone
The interaction works both ways. Certain blood pressure medications can lower your testosterone levels, which is worth knowing because it may influence which antihypertensive your doctor chooses if you are also being treated for low testosterone.
Beta-blockers are the most studied culprits. Research has found that all tested beta-blockers reduced both total and free testosterone, with nonselective agents like propranolol and pindolol producing the greatest suppression.9PubMed. Beta-blocker effects on sexual function in normal males This partly explains the well-known sexual side effects of beta-blockers, including reduced libido and erectile difficulty. If you are taking testosterone for hypogonadism and your blood pressure regimen includes a beta-blocker, the beta-blocker could partially blunt the effect of the testosterone. Switching to a different class of antihypertensive might be reasonable, though that decision depends on the full picture of why you were put on a beta-blocker in the first place.
Calcium channel blockers, another common blood pressure medication class, have also shown testosterone-lowering effects in animal research. Amlodipine, one of the most widely prescribed calcium channel blockers, reduced testosterone levels in a dose-dependent manner in laboratory studies.10Journal of Experimental Pharmacology. Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male Wistar albino rats The human relevance of that finding is uncertain since the study used rats, and the doses may not translate directly. Still, if you are on amlodipine and struggling to reach target testosterone levels despite replacement therapy, this interaction is something to discuss with your prescriber.
ACE inhibitors and angiotensin receptor blockers (ARBs), by contrast, are generally considered neutral or even favorable for testosterone levels. These drugs work by relaxing blood vessels and reducing fluid volume without directly interfering with hormone production. Many clinicians consider ACE inhibitors or ARBs a good fit for men who need both blood pressure control and testosterone therapy, though individual circumstances always guide the choice.
The Cardiovascular Safety Evidence
For years, the biggest concern about combining testosterone with any cardiovascular medication was the fear that testosterone itself might cause heart attacks or strokes. The landmark TRAVERSE trial, published in 2023, was specifically designed to answer this question. It enrolled men with hypogonadism who either had existing cardiovascular disease or were at high risk for it, then randomized them to testosterone gel or placebo and followed them for a median of about three years. Major adverse cardiac events occurred in about 7% of the testosterone group and about 7.3% of the placebo group, meaning testosterone was statistically noninferior to placebo for cardiovascular safety.11PubMed. Cardiovascular Safety of Testosterone-Replacement Therapy
A large observational study of U.S. veterans reinforced those results. Among men without prior heart attacks, strokes, or blood clots, testosterone treatment was not associated with increased risk for these events. In men who already had cardiovascular disease, transdermal testosterone was actually associated with a lower risk of the combined cardiovascular outcome.12PubMed Central. Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities That does not mean testosterone protects the heart, as the study was observational and there could be confounding factors, but it does suggest the therapy is not the cardiac time bomb it was once feared to be.
The current clinical consensus is that in men with confirmed hypogonadism, testosterone replacement does not appear to increase cardiovascular risk when properly monitored. But for men with established cardiovascular disease or significant risk factors, the decision still requires weighing individual risks and benefits carefully.13PubMed Central. Is Testosterone Replacement Safe in Men with Cardiovascular Disease?
What Your Doctor Should Be Monitoring
If you are taking both testosterone and blood pressure medication, expect more frequent check-ins than someone on either alone, especially in the first year. Clinical guidelines recommend checking hematocrit levels every three to six months during the first year of testosterone therapy and annually after that. Blood pressure should be monitored at each visit, and your lipid profile should be checked periodically as well.5International Braz J Urol. Management of Adverse Effects in Testosterone Replacement Therapy
If your blood pressure starts climbing after beginning testosterone, the response is not necessarily to stop testosterone. It might mean adjusting the dose of your antihypertensive, switching to a different class, reducing sodium intake, or changing the testosterone formulation. For men whose hematocrit rises too high, a therapeutic phlebotomy or a dose reduction is usually enough to bring things back in line. The key is catching these changes early through routine monitoring rather than waiting for symptoms.
Men who are prescribed both should also be honest with both their endocrinologist (or urologist) and their cardiologist about all the medications they are taking. Testosterone is sometimes prescribed by clinics that operate outside the traditional healthcare system, and blood pressure management may be handled by a separate primary care provider. When these providers do not communicate, monitoring gaps appear.
Sleep Apnea as a Hidden Complicator
Obstructive sleep apnea deserves special attention when testosterone and blood pressure medicine are in the mix, because it sits at the intersection of all three concerns. Sleep apnea is an independent cause of high blood pressure, it worsens with testosterone use (testosterone can relax the upper airway muscles), and it further raises hematocrit levels through intermittent drops in oxygen during sleep.14PubMed. Does untreated obstructive sleep apnea cause secondary erythrocytosis?
A published case report illustrates how these factors compound each other. A patient with hypogonadism and hard-to-control blood pressure was eventually diagnosed with previously undetected obstructive sleep apnea. Once continuous positive airway pressure therapy was started for the sleep apnea, the patient’s blood pressure stabilized below 130/85 mmHg without any increase in antihypertensive medication, and testosterone therapy could be safely continued and optimized.15Ukrainian Scientific Medical Youth Journal. Restoration of Blood Pressure Control Through Management of Obstructive Sleep Apnea and Optimization of Testosterone Therapy in a Patient with Hypergonadotropic Hypogonadism
If your blood pressure becomes harder to control after starting testosterone, and especially if you snore, feel excessively tired during the day, or wake up gasping, ask about a sleep study. Treating sleep apnea may solve the blood pressure problem without requiring changes to either your testosterone or your antihypertensive regimen.
Testosterone, Erectile Dysfunction, and Blood Pressure Drugs
Many men who seek testosterone therapy are partly motivated by sexual symptoms, particularly erectile dysfunction. Blood pressure medications are also one of the most common drug-related causes of erectile problems. This overlap means the question of taking both is often tied up with sexual health goals.
Research suggests that testosterone alone produces inconsistent results for erectile dysfunction, but that combining testosterone with PDE5 inhibitors like sildenafil or tadalafil can improve outcomes, particularly in men whose low testosterone was making PDE5 inhibitors less effective on their own.16European Urology. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences PDE5 inhibitors also lower blood pressure modestly, which is something to factor in if you are already on antihypertensives. The combination is generally safe but warrants a conversation with your prescriber about the total blood-pressure-lowering load, especially if you take nitrates (which are strictly contraindicated with PDE5 inhibitors for blood pressure reasons).
If a beta-blocker is contributing to your erectile difficulty and suppressing your testosterone, it may make more sense to switch the beta-blocker to an ACE inhibitor or ARB rather than layering on more medications. This kind of coordinated prescribing is where having one doctor aware of the full medication picture matters most.
Testosterone for Transgender Men and Blood Pressure Considerations
The question of testosterone and blood pressure is not limited to cisgender men with hypogonadism. Transgender men receiving testosterone as part of gender-affirming hormone therapy face many of the same considerations, with some additional wrinkles. They are typically starting from a premenopausal female hormonal baseline, where blood pressure tends to be lower than in age-matched men.17Cardiovascular Research. Sex hormones and hypertension Moving to male-range testosterone levels shifts blood pressure upward on average, though the magnitude varies.
A systematic review examining cardiovascular mortality in transgender men on testosterone therapy found an incidence rate of roughly 1.8 cardiovascular deaths per 1,000 person-years across studies including nearly 8,000 individuals.18PubMed Central. Cardiovascular mortality associated with testosterone therapy in cisgender women and transgender men: a systematic review Contextualizing that rate is tricky because comparison groups vary and many transgender men are younger than the typical cisgender male testosterone patient, but it underscores that cardiovascular monitoring applies equally regardless of the reason for testosterone use. Blood pressure checks, hematocrit monitoring, and awareness of sleep apnea risk are just as important in this population, and arguably more important given that routine cardiovascular screening in transgender healthcare has historically been inconsistent.